Drawing for SMR²T BY MIMEDX

USPTO serial 88718272

SMR²T BY MIMEDX

Reviewed by CopyMark Law Group

Reg. 6531459Status 700Renewal
Filing date
Status date
Registration date
Oct 19, 2021
Examiner
MACFARLANE, JAMES W
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SMR²T BY MIMEDX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marcy L. Sperry, Esq.

Marcy L. Sperry, Esq. Sperry IP Law LLC dba Vivid IP3017 Bolling Way NEAtlanta, GA 30305UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Topical treatment in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; Topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; wound treatment in the nature of a micronized powder comprising amniotic material for medical purposes; wound treatment in the nature of a dressing comprising amniotic material; allograft made from amniotic materialACTIVEJun 21, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 19, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 19, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 15, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 14, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 13, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 13, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 3, 2021IUAFUSE AMENDMENT FILED—
Aug 3, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 18, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 16, 2021EX1GSOU EXTENSION 1 GRANTED—
Feb 16, 2021EXT1SOU EXTENSION 1 FILED—
Feb 16, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 22, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 28, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 28, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 8, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 24, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 28, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 28, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 28, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 3, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 3, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 3, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 17, 2020CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Mar 17, 2020ALIEASSIGNED TO LIE—
Mar 16, 2020GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Mar 16, 2020GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Mar 16, 2020CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Mar 7, 2020DOCKASSIGNED TO EXAMINER—
Dec 11, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 10, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance